Pregnancy in Wilson's disease: Management and outcome
Conclusion: Pregnancy in WD patients on anticopper therapy is safe. The spontaneous abortion rate in treated patients was lower than that in therapy‐naïve patients. Although the teratogenic potential of copper chelators is a concern, the rate of birth defects in our cohort was low. Treatment for WD should be maintained during pregnancy, and patients should be monitored closely for hepatic and neurological symptoms. (Hepatology 2017).
Source: Hepatology - Category: Internal Medicine Authors: Jan Pfeiffenberger, Sandra Beinhardt, Daniel N. Gotthardt, Nicola Haag, Clarissa Freissmuth, Ulrike Reuner, Annika Gauss, Wolfgang Stremmel, Michael L. Schilsky, Peter Ferenci, Karl Heinz Weiss Tags: Steatohepatitis and Metabolic Liver Disease Source Type: research
More News: Brain | Copper | Internal Medicine | Liver | Liver Disease | Miscarriage | Neurology | Pregnancy | Study | Toxicology | Urology & Nephrology | Wilson's Disease